💨 Abstract

A new weight loss pill, Orforglipron, is showing promise in trials for treating Type 2 diabetes and obesity. If approved, it could aid in Britain's weight problem as participants lost an average of 16 pounds in nine months without weight loss stopping after the trial period.

Courtesy: metro.co.uk

Summarized by Einstein Beta 🤖

Powered by MessengerX.io